NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) — Cash Flow Quality Index

Latest as of September 2025: -0.83x

NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Cash Flow Quality Index of -0.83x as of September 2025. Operating cash flow of $-32.77 Million is below net income of $39.53 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore NewAmsterdam Pharma Company N.V. Ordinar debt service capacity to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.83x

Operating CF / Net Income

Operating Cash Flow

$-32.77 Million

USD

Net Income

$39.53 Million

USD

Data as of

Sep 2025

Most recent filing

Annual Cash Flow Quality Index for NewAmsterdam Pharma Company N.V. Ordinary Shares (None–None)

Year-by-year earnings quality comparison for NewAmsterdam Pharma Company N.V. Ordinary Shares.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.